Amidst a surge in COVID-19 cases in India, the CEO of the Serum Institute of India (SII), Adar Poonawalla, stated on Saturday that the current strain of the virus is mild. He also mentioned that SII has already manufactured around 5-6 million doses of the Covovax vaccine. Poonawalla's remarks were made during a media interaction regarding the ongoing pandemic situation in the country. Source: ANI